Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Drug Antagonism”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Parameters of drug antagonism: re-examination of two modes of functional competitive drug antagonism on intraocular muscles.

There are two distinct kinetic functional pharmacological procedures by which the equilibrium affinity constant, KB, of a competitive reversible blocker is obtained. The classical method on an organ system requires the study of the parallel displacement of the agonist concentration-response curve in the presence of the blocker. In the second method, the agonist-evoked functional mechanical response is reduced to half by the blocker IC50 (the concentration required for 50% inhibition). In relation to these parameters the role of the ionization constant pKa and liposolubility log Pc or log D of blockers was examined. On the ciliary muscle from human eye, IC50/KB ratios for (+/-)-atropine, its quaternary analogue (+/-)-methylatropine, (-)-scopolamine, (+/-)-cyclopentolate, (-)-tropicamide, (+/-)-oxybutynin and pirenzepine were 15, 23, 4.4, 2.6, 1.66, 1.46 and 1.71, respectively. The ratios on the iris sphincter were comparable with those of ciliary muscle. When compared with large proportions of ionized molecules with water soluble properties of (+/-)-atropine and (+/-)-methylatropine, relatively high amounts of un-ionized and/or with greater partitioning of all other blockers in the lipoid barrier correlated well to low IC50/KB ratios, as predicted by the classical theory of competitive drug antagonism. It was hypothesized that due to receptor biophase access, the reduction of the mechanical response of the agonist by the highly ionized water-soluble antagonist at IC50 represented time-distorted "pseudoequilibrium" estimation, where a higher concentration of the blocker was needed. On the other cholinergic effectors, like that of rat anococcygeus muscle or frog rectus abdominus muscle, IC50/KB ratios of respective blockers atropine or (+)-tubocurarine and hexamethonium were close to 1. Thus physicochemical properties, which affect the distribution coefficient log D and the tissue morphology (where asymmetric distribution of receptors may occur), appeared to be a critical factor in the analysis of the affinity parameters of the competitive reversible blocker. On the intraocular muscles, two functional pharmacological procedures for obtaining KB and IC50 values were not kinetically equivalent.

Abdominal Muscles↗

DRUG ANTAGONISM.

Explore the source record for details and available documents.

Antimetabolites↗

Postjunctional supersensitivity of the smooth muscle of the rat vas deferens induced by calmodulin-antagonizing drugs applied locally to the hypogastric plexus.

Local application of 100 micrograms of chlorpromazine hydrochloride (CPZ) to the hypogastric plexus of the rat produced supersensitivity of the smooth muscle of the vas deferens. In comparison with surgical denervation, CPZ produced a similar increase in the maximum response but less leftward shift of the dose-response curves to norepinephrine. The changes in dose response curves to methacholine and potassium induced by CPZ were substantially similar to those induced by denervation. Virtually identical supersensitivity was brought about in the rat vas deferens by the same treatment with other drugs which possess calmodulin-antagonizing actions. CPZ produced no change in norepinephrine content of the tissue. Contractile responses of the tissue to tyramine were markedly potentiated by CPZ, but the responses to nerve stimulation were not significantly altered except for that at the lowest frequency. In electrophysiologic studies, while spontaneous junction potentials could be detected in all of the impaled cells, they occurred with lesser frequency and smaller amplitude in all of the impaled cells in the CPZ-treated rat vas deferens than in the control tissue. Nevertheless, the junction and action potentials could be induced by nerve stimulation in all smooth muscle cells. The results indicate that CPZ and also other drugs used in the present study produced postjunctional supersensitivity accompanied by a large increase in the maximum response, but almost no prejunctional supersensitivity in the rat vas deferens.

Animals↗

DRUG ANTAGONISM BETWEEN LINCOMYCIN AND ERYTHROMYCIN.

An antagonistic action can be demonstrated between lincomycin, a new antibiotic, and erythromycin, when the two drugs are allowed to diffuse into the same area of an agar plate seeded with a strain of Staphylococcus which is resistant to erythromycin but sensitive to lincomycin. The increase in the minimum inhibitory concentrations of lincomycin in the presence of erythromycin may be significant in clinical application. The antagonism does not depend on a reaction between the two antibiotics, but appears to be the result of an altered metabolism stimulated by erythromycin on erythromycin-resistant staphylococci.

Anti-Bacterial Agents↗

[Drug antagonism].

The mechanisms responsible of either a loss of therapeutic efficiency or a beneficial cancellation of toxic phenomena are reviewed. References are specifically made to antagonists of anti-vitamin K, oral contraceptives, antihypertensive drugs and statin. Concerning the antidotes, the importance of anti-digoxin antibodies, naloxone and flumazenil is emphasised.

Anticholesteremic Agents↗

Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics.

The psychotomimetic actions of the partial-agonist analgesic drugs cyclazocine and levallophan have been demonstrated using a quantitative behavioural test in young rats which measures lateral head movements and pivoting on the hind paws. This drug induced behaviour is antagonized by low doses of the dopaminergic agonists apomorphine and piribedil, the dopamine releasing drug amphetamine, the dopamine reuptake blocking agent benztropine and by large doses of the dopamine precursor L-Dopa. Naloxone antagonize the behaviour, but only at one hundred times the analgesic antagonist dose. These results show that dopaminergic systems are implicated in the mechanism of action of partial-agonist induced psychotomimetic side effects.

Amphetamine↗